Combination immunotherapy for the treatment of cancer

  • US 9,375,475 B2
  • Filed: 04/10/2014
  • Issued: 06/28/2016
  • Est. Priority Date: 09/30/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating cancer in a patient comprising administering to the patient simultaneously or sequentially a blocking anti-PD-1 antibody and an ICOS ligand (ICOS-L).

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×